- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
SciClone Pharmaceuticals Inc+ Add to Watchlist
SCLN:US8.8500 USD 0.2200 2.43%
As of 20:10:00 ET on 12/19/2014.
Company Profile for SciClone Pharmaceuticals Inc (SCLN)
SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company that acquires, develops, and commercializes specialist-oriented drugs. The Company's products are for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and immune system disorders.
SciClone Pharmaceuticals Inc
Key Executives for SciClone Pharmaceuticals Inc (SCLN)
|Friedhelm BlobelPresident/CEO||Hong ZhaoCEO:China Operations|
|Wilson W CheungSenior VP:Finance/CFO||Charles MengVP:Compliance/General Counsel|
|Lan XieVP:Finance/CFO:China Operations||Raymond A LowVP:Finance/Controller|
|Min YinVP:Internal Audit|